Citation: | FAN Shanhong, XUE Hong, XU Wen, GE Wei, SHEN Li, DONG Yu, FU Ting, HE Zhen, GENG Jie. Construction and implementation of a collaborative work system between designated hospitals and infection control departments during a local outbreak of Coronavirus disease 2019 infection[J]. Chinese Journal of General Practice, 2023, 21(12): 2151-2155. doi: 10.16766/j.cnki.issn.1674-4152.003311 |
[1] |
HUANG C L, WANG Y M, LI X W, et al. Clinical features of patients infected infected with 2019 novel coronavirus in Wuhan, China[J]. Lancet, 2020, 395: 497. doi: 10.1016/S0140-6736(20)30183-5
|
[2] |
DHAMA K, KHAN S, TIWARI R, et al. Coronavirus Disease 2019-COVID-19[J]. Clin Microbiol Rev, 2020, 33(4): e00028-20. DOI: 10.1128/cmr.00028-20.
|
[3] |
房元圣, 武洁雯, 赵青, 等. 2023年7月全球新型冠状病毒感染疫情风险评估[J]. 疾病监测, 2023, 38(8): 901-904.
FANG Y S, WU J W, ZHAO Q, et al. Risk assessment of global COVID-19 pandemic in July 2023[J]. Disease Surveillance, 2023, 38(8): 901-904.
|
[4] |
陈文森, 张浩军, 李六亿, 等. 超大型城市新型冠状病毒肺炎局部暴发疫情防控策略[J]. 中华医院感染学杂志, 2021, 31(24): 3687-3690.
CHEN W S, ZHANG H J, LI L Y, et al. Research on control and prevention strategy of COVID-19 in metropolis[J]. Chinese Journal of Nosocomiology, 2021, 31(24): 3687-3690.
|
[5] |
IACOBUCCI G. Covid-19: are high rates of B. 1.617.2 linked to vaccine hesitancy?[J]BMJ, 2021, 373: n1345. DOI: 10.1136/bmj.n1345.
|
[6] |
MLCOCHOVA P, KEMP S A, DHAR M S, et al. SARS-CoV-2 B. 1.617.2 Delta variant replication and immune evasion[J]. Nature, 2021. DOI: 10.1038/s41586-021-03944-y.
|
[7] |
史庆丰, 高晓东, 胡必杰. Delta新冠病毒变异株的特性及流行现状与防控研究进展[J]. 中华医院感染学杂志, 2021, 31(24): 3703-3707.
SHI Q F, GAO X D, HU B J. Research progress on characteristics, epidemiology and control measure of SARS-CoV-2 Delta VOC[J]. Chinese Journal of Nosocomiology, 2021, 31(24): 3703-3707.
|
[8] |
LIU Y, ROCKLOV J. The reproductive number of the Delta variant of SARS-CoV-2 is far higher compared to the ancestral SARS-CoV-2 virus[J]. J Travel Med, 2021, 28(7): taab124. DOI: 10.1093/jtm/taab124.
|
[9] |
ALISHAQ M, JEREMIJENKO A, AL-KANNAANI Z, et al. Prevalence and risk factors for SARS-CoV-2 infection and seroprevalence among clinical and non-clinical staff in a national health care system[J]. PLoS One, 2021, 16(9): e0257845. DOI: 10.1371/journal.pone.0257845.
|
[10] |
GALANIS P, VRAKA I, FRAGKOU D, et al. Seroprevalence of SARS-CoV-2 antibodies and associated factors in healthcare workers: a systematic review and meta-analysis[J]. J Hosp Infect, 2021, 108: 120-134. DOI: 10.1016/j.jhin.2020.11.008.
|
[11] |
KLOMPAS M, BAKER M A, RHEE C, et al. A SARS-CoV-2 Clusterinan acute care hospital[J]. Ann Intern Med, 2021, 174(6): 794-802. doi: 10.7326/M20-7567
|
[12] |
李六亿, 姚希, 张冰丽. 新冠肺炎患者救治定点医院改建对策[J]. 中华医院感染学杂志, 2021, 31(19): 2881-2885.
I L Y, YAO X, ZHANG B L. Countermeasures for the reconstruction of designated hospitals for the treatment of patients with COVID-19[J]. Chinese Journal of Nosocomiology, 2021, 31(19): 2881-2885.
|
[13] |
张浩军, 陈文森, 高晓东, 等. 应对新冠肺炎局部暴发疫情定点医院感染防控工作模式思考[J]. 中华医院感染学杂志, 2021, 31(24), 3691-3694.
ZHANG H J, CHEN W S, GAO X D, et al. Consideration of the infection prevention and control mode in designated hospitals in response to local outbreaks of COVID-19[J]. Chinese Journal of Nosocomiology, 2021, 31(24), 3691-3694.
|
[14] |
符敏, 胡少华, 王婷, 等. 安徽省公立医院护士医用防护用品知识现状调查[J]. 中华全科医学, 2022, 20(1): 144-147. doi: 10.16766/j.cnki.issn.1674-4152.002298
FU M, HU S H, WANG T, et al. Investigation on the current situation of knowledge of medical protective equipment amongst nurses in public hospitals in Anhui Province[J]. Chinese Journal of General Practice, 2022, 20(1): 144-147. doi: 10.16766/j.cnki.issn.1674-4152.002298
|
[15] |
钟霞, 李伟, 郭德莹, 等. COVID-19流行期间非定点收治三级综合医院感染防控实践的探索[J]. 中华全科医学, 2020, 18(12): 2117-2119, 2148. doi: 10.16766/j.cnki.issn.1674-4152.001702
ZHONG X, LI W, GUO D Y, et al. Practice of infection prevention and control in non-designated three grade general hospital during COVID-19 epidemic period[J]. Chinese Journal of General Practice, 2020, 18(12): 2117-2119, 2148. doi: 10.16766/j.cnki.issn.1674-4152.001702
|
[16] |
付强. 基于COVID-19疫情应对的医疗机构内感染防控实践思考[J]. 中华医院感染学杂志, 2020, 30(8): 1121-1124.
FU Q. Reflection on practice of prevention and control of infection in medical institutions based on response to COVID-19 epidemic[J]. Chinese Journal of Nosocomiology, 2020, 30(8): 1121-1124.
|
[17] |
李红, 江莉, 石月欣, 等. 新型冠状病毒肺炎定点医院中院感防控体系的构建和作用[J]. 环境卫生学杂志, 2021, 11(2): 220-223.
LI H, JIANG L, SHI Y X, et al. Construction and role of a nosocomial infection prevention and control system in designated hospitals for COVID-19[J]. Journal of Environmental Hygiene, 2021, 11(2): 220-223.
|